spacer
spacer

PDBsum entry 1g3f

Go to PDB code: 
protein ligands metals links
Apoptosis PDB id
1g3f

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
117 a.a. *
Ligands
ALA-VAL-PRO-ILE-
ALA-GLN-LYS-SER-
GLU
Metals
_ZN
* Residue conservation analysis
PDB id:
1g3f
Name: Apoptosis
Title: Nmr structure of a 9 residue peptide from smac/diablo complexed to the bir3 domain of xiap
Structure: Inhibitor of apoptosis protein 3. Chain: a. Fragment: residues 241-356. Synonym: x-linked inhibitor of apoptosis protein, xiap. Engineered: yes. Smac. Chain: b. Fragment: 9 residue peptide. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the 9 residue peptide was chemically synthesized.
NMR struc: 1 models
Authors: Z.Liu,C.Sun,E.T.Olejniczak,R.P.Meadows,S.F.Betz,T.Oost,J.Herrmann, J.C.Wu,S.W.Fesik
Key ref:
Z.Liu et al. (2000). Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature, 408, 1004-1008. PubMed id: 11140637 DOI: 10.1038/35050006
Date:
24-Oct-00     Release date:   10-Jan-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P98170  (XIAP_HUMAN) -  E3 ubiquitin-protein ligase XIAP from Homo sapiens
Seq:
Struc:
497 a.a.
117 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.27  - RING-type E3 ubiquitin transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine

 

 
DOI no: 10.1038/35050006 Nature 408:1004-1008 (2000)
PubMed id: 11140637  
 
 
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
Z.Liu, C.Sun, E.T.Olejniczak, R.P.Meadows, S.F.Betz, T.Oost, J.Herrmann, J.C.Wu, S.W.Fesik.
 
  ABSTRACT  
 
The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes. Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the IAPs and promotes caspase activation. Although undefined in the X-ray structure, the amino-terminal residues of Smac are critical for its function. To understand the structural basis for molecular recognition between Smac and the IAPs, we determined the solution structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac. The peptide binds across the third beta-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein. The complex is stabilized by four intermolecular hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions. This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small molecules that may be used for the treatment of cancers that overexpress IAPs.
 
  Selected figure(s)  
 
Figure 1.
Figure 1: Similarity of IAP BIR domains and N-terminal sequences of IAP binding proteins. a, Sequence alignment of the BIR domains and surrounding residues of IAPs that bind to Smac or to Reaper, Hid and Grim. Identical residues are highlighted in blue, and highly homologous residues are highlighted in green. Residues that have intermolecular NOEs to the Smac peptide are indicated with asterisks. The secondary structural elements in the NMR structure of BIR3 are shown above the sequence. Circles denote the residues that were mutated and tested for caspase-9 inhibition (blue) and Smac peptide binding (red). Filled circles indicate a >10-fold decrease in caspase-9 inhibition or Smac peptide binding, half-filled circles indicate >5-fold decrease, and open circles indicate mutants that have no significant effect. b, Sequence alignment of the N-terminal residues of mature Smac, Hid, Reaper and Grim. Residue 1 of mature Smac corresponds to residue 56 of unprocessed Smac.
Figure 2.
Figure 2: Structure of the XIAP BIR3 domain/Smac peptide complex.
Figure 2 : Structure of the XIAP BIR3 domain/Smac peptide complex. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com-
a, Stereo view of 30 superimposed NMR-derived structures of the BIR3 domain of XIAP (showing residues 258–346) complexed to the Smac peptide (showing residues 1'–4'). The Smac peptide is colour-coded by atom type. The root mean square deviation (r.m.s.d.) to the mean coordinate positions for residues 260–345 of the protein is 0.38 0.04 Å for the backbone atoms (N, C^ , C') and 0.78 0.05 Å for all heavy atoms. The distance restraint force constant was 50 kcal mol^-1 Å ^-2, and no NOE was violated by more than 0.4 Å. The final energy of the NOE constraints (ENOE) was 24 13 kcal mol^-1. The torsion restraint force constant was 200 kcal mol^-1 rad^-2, and no torsion restraint was violated by more than 5°. Only the covalent geometry terms, NOE, torsion, and repulsive van der Waals terms were employed in the refinement. Even so, a large, negative Lennard–Jones potential energy was observed (-399 13 kcal mol^-1), indicating good non-bonded geometry. Procheck^25 analysis indicated that 97% of the residues are in allowed regions of the Ramachandran map. b, Ribbons^27 representation of the averaged minimized NMR structure of the XIAP BIR3/Smac peptide complex. c, Close-up of the binding site. The carbon atoms of the Smac peptide (A1'–I4') are shown in white. d, Surface representation of the binding site of the BIR3 domain bound to the Smac peptide.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nature (2000, 408, 1004-1008) copyright 2000.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22293567 S.Fulda, and D.Vucic (2012).
Targeting IAP proteins for therapeutic intervention in cancer.
  Nat Rev Drug Discov, 11, 109-124.  
21274634 H.Wang, and R.J.Clem (2011).
The role of IAP antagonist proteins in the core apoptosis pathway of the mosquito disease vector Aedes aegypti.
  Apoptosis, 16, 235-248.  
21354220 L.Flanagan, J.Sebastia, M.E.Delgado, J.C.Lennon, and M.Rehm (2011).
Dimerization of Smac is crucial for its mitochondrial retention by XIAP subsequent to mitochondrial outer membrane permeabilization.
  Biochim Biophys Acta, 1813, 819-826.  
20734142 T.S.Griffith, T.A.Kucaba, M.A.O'Donnell, J.Burns, C.Benetatos, M.A.McKinlay, S.Condon, and S.Chunduru (2011).
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
  Apoptosis, 16, 13-26.  
20705815 A.E.Kelly, C.Ghenoiu, J.Z.Xue, C.Zierhut, H.Kimura, and H.Funabiki (2010).
Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B.
  Science, 330, 235-239.  
20632385 A.R.Hussain, S.Uddin, M.Ahmed, R.Bu, S.O.Ahmed, J.Abubaker, M.Sultana, D.Ajarim, F.Al-Dayel, P.P.Bavi, and K.S.Al-Kuraya (2010).
Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
  J Pathol, 222, 180-190.  
20704571 D.C.Altieri (2010).
Survivin and IAP proteins in cell-death mechanisms.
  Biochem J, 430, 199-205.  
20461078 D.Lecis, C.Drago, L.Manzoni, P.Seneci, C.Scolastico, E.Mastrangelo, M.Bolognesi, A.Anichini, H.Kashkar, H.Walczak, and D.Delia (2010).
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.
  Br J Cancer, 102, 1707-1716.  
20844561 E.Weisberg, A.Ray, R.Barrett, E.Nelson, A.L.Christie, D.Porter, C.Straub, L.Zawel, J.F.Daley, S.Lazo-Kallanian, R.Stone, I.Galinsky, D.Frank, A.L.Kung, and J.D.Griffin (2010).
Smac mimetics: implications for enhancement of targeted therapies in leukemia.
  Leukemia, 24, 2100-2109.  
20622902 E.Weisberg, M.Sattler, A.Ray, and J.D.Griffin (2010).
Drug resistance in mutant FLT3-positive AML.
  Oncogene, 29, 5120-5134.  
20651737 M.Gyrd-Hansen, and P.Meier (2010).
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
  Nat Rev Cancer, 10, 561-574.  
19373243 P.D.Mace, S.Shirley, and C.L.Day (2010).
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins.
  Cell Death Differ, 17, 46-53.  
20547836 S.L.Petersen, M.Peyton, J.D.Minna, and X.Wang (2010).
Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
  Proc Natl Acad Sci U S A, 107, 11936-11941.  
  20957035 S.P.Burke, and J.B.Smith (2010).
Monomerization of cytosolic mature smac attenuates interaction with IAPs and potentiation of caspase activation.
  PLoS One, 5, 0.  
19667203 A.Krieg, R.G.Correa, J.B.Garrison, G.Le Negrate, K.Welsh, Z.Huang, W.T.Knoefel, and J.C.Reed (2009).
XIAP mediates NOD signaling via interaction with RIP2.
  Proc Natl Acad Sci U S A, 106, 14524-14529.  
19660030 C.D.Moore, H.Wu, B.Bolaños, S.Bergqvist, A.Brooun, T.Pauly, and D.Nowlin (2009).
Structural and biophysical characterization of XIAP BIR3 G306E mutant: insights in protein dynamics and application for fragment-based drug design.
  Chem Biol Drug Des, 74, 212-223.  
19736924 C.Y.Yang, H.Sun, J.Chen, Z.Nikolovska-Coleska, and S.Wang (2009).
Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction.
  J Am Chem Soc, 131, 13709-13721.  
19308633 E.T.Beck, S.Lozano Fuentes, D.A.Geske, C.D.Blair, B.J.Beaty, and W.C.Black (2009).
Patterns of variation in the inhibitor of apoptosis 1 gene of Aedes triseriatus, a transovarial vector of La Crosse virus.
  J Mol Evol, 68, 403-413.  
19552815 I.Hammami, S.Amara, M.Benahmed, M.V.El May, and C.Mauduit (2009).
Chronic crude garlic-feeding modified adult male rat testicular markers: mechanisms of action.
  Reprod Biol Endocrinol, 7, 65.  
19284370 J.A.Flygare, and D.Vucic (2009).
Development of novel drugs targeting inhibitors of apoptosis.
  Future Oncol, 5, 141-144.  
  20419043 J.Shi, Q.He, J.An, H.Sun, Y.Huang, and M.S.Sheikh (2009).
Sulindac Sulfide Differentially Induces Apoptosis in Smac-Proficient and -Deficient Human Colon Cancer Cells.
  Mol Cell Pharmacol, 1, 92-97.  
19112105 K.Kadohara, M.Nagumo, S.Asami, Y.Tsukumo, H.Sugimoto, M.Igarashi, K.Nagai, and T.Kataoka (2009).
Caspase-8 Mediates Mitochondrial Release of Pro-apoptotic Proteins in a Manner Independent of Its Proteolytic Activity in Apoptosis Induced by the Protein Synthesis Inhibitor Acetoxycycloheximide in Human Leukemia Jurkat Cells.
  J Biol Chem, 284, 5478-5487.  
19021159 M.Orzáez, A.Gortat, L.Mondragón, and E.Pérez-Payá (2009).
Peptides and peptide mimics as modulators of apoptotic pathways.
  ChemMedChem, 4, 146-160.  
  20209078 Q.He, J.Shi, S.Jones, J.An, Y.Liu, Y.Huang, and M.S.Sheikh (2009).
Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells.
  Mol Cell Pharmacol (Windsor Mill), 1, 23-28.  
19138149 W.Sun, Z.Nikolovska-Coleska, D.Qin, H.Sun, C.Y.Yang, L.Bai, S.Qiu, Y.Wang, D.Ma, and S.Wang (2009).
Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases.
  J Med Chem, 52, 593-596.  
19895686 Y.Dai, M.Liu, W.Tang, Y.Li, J.Lian, T.S.Lawrence, and L.Xu (2009).
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
  BMC Cancer, 9, 392.  
  19966933 Y.Dai, T.S.Lawrence, and L.Xu (2009).
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
  Am J Transl Res, 1, 1.  
18239672 B.P.Eckelman, M.Drag, S.J.Snipas, and G.S.Salvesen (2008).
The mechanism of peptide-binding specificity of IAP BIR domains.
  Cell Death Differ, 15, 920-928.  
19012392 B.Zhang, Z.Nikolovska-Coleska, Y.Zhang, L.Bai, S.Qiu, C.Y.Yang, H.Sun, S.Wang, and Y.Wu (2008).
Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases.
  J Med Chem, 51, 7352-7355.  
18844293 C.B.Bourguet, D.Sabatino, and W.D.Lubell (2008).
Benzophenone semicarbazone protection strategy for synthesis of aza-glycine containing aza-peptides.
  Biopolymers, 90, 824-831.  
18438971 C.Obiol-Pardo, J.M.Granadino-Roldán, and J.Rubio-Martinez (2008).
Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
  J Mol Recognit, 21, 190-204.  
18931692 E.C.LaCasse, D.J.Mahoney, H.H.Cheung, S.Plenchette, S.Baird, and R.G.Korneluk (2008).
IAP-targeted therapies for cancer.
  Oncogene, 27, 6252-6275.  
18954041 H.Sun, J.A.Stuckey, Z.Nikolovska-Coleska, D.Qin, J.L.Meagher, S.Qiu, J.Lu, C.Y.Yang, N.G.Saito, and S.Wang (2008).
Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
  J Med Chem, 51, 7169-7180.
PDB code: 2jk7
18937395 H.Sun, Z.Nikolovska-Coleska, C.Y.Yang, D.Qian, J.Lu, S.Qiu, L.Bai, Y.Peng, Q.Cai, and S.Wang (2008).
Design of small-molecule peptidic and nonpeptidic Smac mimetics.
  Acc Chem Res, 41, 1264-1277.  
17967870 J.C.Wilkinson, A.S.Wilkinson, S.Galbán, R.A.Csomos, and C.S.Duckett (2008).
Apoptosis-inducing factor is a target for ubiquitination through interaction with XIAP.
  Mol Cell Biol, 28, 237-247.  
18306465 J.K.Yang (2008).
FLIP as an anti-cancer therapeutic target.
  Yonsei Med J, 49, 19-27.  
18407359 J.M.Hallett, A.E.Leitch, N.A.Riley, R.Duffin, C.Haslett, and A.G.Rossi (2008).
Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation.
  Trends Pharmacol Sci, 29, 250-257.  
  18563329 J.Wang, F.Zeng, L.Wang, Z.Zhu, and G.Jiang (2008).
Synthetic Smac peptide enhances chemo-sensitivity of bladder cancer cells.
  J Huazhong Univ Sci Technolog Med Sci, 28, 304-307.  
18485876 L.Wang, F.Du, and X.Wang (2008).
TNF-alpha induces two distinct caspase-8 activation pathways.
  Cell, 133, 693-703.  
18854135 M.X.O'Riordan, L.D.Bauler, F.L.Scott, and C.S.Duckett (2008).
Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation.
  Dev Cell, 15, 497-508.  
18037921 P.Taylor, E.Blackburn, Y.G.Sheng, S.Harding, K.Y.Hsin, D.Kan, S.Shave, and M.D.Walkinshaw (2008).
Ligand discovery and virtual screening using the program LIDAEUS.
  Br J Pharmacol, 153, S55-S67.  
18729734 S.M.Best (2008).
Viral subversion of apoptotic enzymes: escape from death row.
  Annu Rev Microbiol, 62, 171-192.  
18620520 S.M.Langemeijer, A.O.de Graaf, and J.H.Jansen (2008).
IAPs as therapeutic targets in haematological malignancies.
  Expert Opin Ther Targets, 12, 981-993.  
18573080 V.N.Uversky, C.J.Oldfield, and A.K.Dunker (2008).
Intrinsically disordered proteins in human diseases: introducing the D2 concept.
  Annu Rev Biophys, 37, 215-246.  
19047096 Y.Dai, M.Liu, W.Tang, J.DeSano, E.Burstein, M.Davis, K.Pienta, T.Lawrence, and L.Xu (2008).
Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
  Clin Cancer Res, 14, 7701-7710.  
19049347 Y.Peng, H.Sun, Z.Nikolovska-Coleska, S.Qiu, C.Y.Yang, J.Lu, Q.Cai, H.Yi, S.Kang, D.Yang, and S.Wang (2008).
Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases.
  J Med Chem, 51, 8158-8162.  
18350282 Y.Umezawa (2008).
Detecting mitochondrial RNA and other cellular events in living cells.
  Anal Bioanal Chem, 391, 1591-1598.  
20636084 Y.Umezawa (2008).
Optical probes for molecular processes in live cells.
  Annu Rev Anal Chem (Palo Alto Calif), 1, 397-421.  
18717598 Z.Nikolovska-Coleska, J.L.Meagher, S.Jiang, C.Y.Yang, S.Qiu, P.P.Roller, J.A.Stuckey, and S.Wang (2008).
Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein.
  Biochemistry, 47, 9811-9824.
PDB code: 2vsl
17094177 A.Kurakin, and D.E.Bredesen (2007).
An unconventional IAP-binding motif revealed by target-assisted iterative screening (TAIS) of the BIR3-cIAP1 domain.
  J Mol Recognit, 20, 39-50.  
17573556 A.M.Hunter, E.C.LaCasse, and R.G.Korneluk (2007).
The inhibitors of apoptosis (IAPs) as cancer targets.
  Apoptosis, 12, 1543-1568.  
16794601 A.M.Verhagen, T.K.Kratina, C.J.Hawkins, J.Silke, P.G.Ekert, and D.L.Vaux (2007).
Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs.
  Cell Death Differ, 14, 348-357.  
17382285 A.R.Mufti, E.Burstein, and C.S.Duckett (2007).
XIAP: cell death regulation meets copper homeostasis.
  Arch Biochem Biophys, 463, 168-174.  
17339366 C.A.Karikari, I.Roy, E.Tryggestad, G.Feldmann, C.Pinilla, K.Welsh, J.C.Reed, E.P.Armour, J.Wong, J.Herman, D.Rakheja, and A.Maitra (2007).
Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.
  Mol Cancer Ther, 6, 957-966.  
17032924 D.Chauhan, P.Neri, M.Velankar, K.Podar, T.Hideshima, M.Fulciniti, P.Tassone, N.Raje, C.Mitsiades, N.Mitsiades, P.Richardson, L.Zawel, M.Tran, N.Munshi, and K.C.Anderson (2007).
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
  Blood, 109, 1220-1227.  
17999504 H.Sun, Z.Nikolovska-Coleska, J.Lu, J.L.Meagher, C.Y.Yang, S.Qiu, Y.Tomita, Y.Ueda, S.Jiang, K.Krajewski, P.P.Roller, J.A.Stuckey, and S.Wang (2007).
Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
  J Am Chem Soc, 129, 15279-15294.  
17479107 J.Wei, J.Wahl, H.Knauss, S.Zeller, G.Jarmy, G.Fitze, K.M.Debatin, and C.Beltinger (2007).
Cytosine deaminase/5-fluorocytosine gene therapy and Apo2L/TRAIL cooperate to kill TRAIL-resistant tumor cells.
  Cancer Gene Ther, 14, 640-651.  
17450518 J.Y.Liou, N.Matijevic-Aleksic, S.Lee, and K.K.Wu (2007).
Prostacyclin inhibits endothelial cell XIAP ubiquitination and degradation.
  J Cell Physiol, 212, 840-848.  
17557079 M.Challa, S.Malladi, B.J.Pellock, D.Dresnek, S.Varadarajan, Y.W.Yin, K.White, and S.B.Bratton (2007).
Drosophila Omi, a mitochondrial-localized IAP antagonist and proapoptotic serine protease.
  EMBO J, 26, 3144-3156.  
17560374 M.Lu, S.C.Lin, Y.Huang, Y.J.Kang, R.Rich, Y.C.Lo, D.Myszka, J.Han, and H.Wu (2007).
XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.
  Mol Cell, 26, 689-702.
PDB codes: 2poi 2pom 2pop
17996648 S.L.Petersen, L.Wang, A.Yalcin-Chin, L.Li, M.Peyton, J.Minna, P.Harran, and X.Wang (2007).
Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.
  Cancer Cell, 12, 445-456.  
17724022 Z.Gao, Y.Tian, J.Wang, Q.Yin, H.Wu, Y.M.Li, and X.Jiang (2007).
A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo.
  J Biol Chem, 282, 30718-30727.  
16322751 A.D.Schimmer, S.Dalili, R.A.Batey, and S.J.Riedl (2006).
Targeting XIAP for the treatment of malignancy.
  Cell Death Differ, 13, 179-188.  
16749867 A.Malugin, P.Kopecková, and J.Kopecek (2006).
HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.
  Mol Pharm, 3, 351-361.  
17009316 D.C.Fry (2006).
Protein-protein interactions as targets for small molecule drug discovery.
  Biopolymers, 84, 535-552.  
16891304 E.Varfolomeev, S.M.Wayson, V.M.Dixit, W.J.Fairbrother, and D.Vucic (2006).
The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
  J Biol Chem, 281, 29022-29029.  
16567363 F.Ortuso, T.Langer, and S.Alcaro (2006).
GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition.
  Bioinformatics, 22, 1449-1455.  
16646083 H.L.Li, A.B.Wang, R.Zhang, Y.S.Wei, H.Z.Chen, Z.G.She, Y.Huang, D.P.Liu, and C.C.Liang (2006).
A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages.
  J Cell Physiol, 208, 307-318.  
17005722 J.C.Tapia, V.A.Torres, D.A.Rodriguez, L.Leyton, and A.F.Quest (2006).
Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
  Proc Natl Acad Sci U S A, 103, 15079-15084.  
16575541 K.Mizukawa, A.Kawamura, T.Sasayama, K.Tanaka, M.Kamei, M.Sasaki, and E.Kohmura (2006).
Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines.
  J Neurooncol, 77, 247-255.  
19617919 S.K.Sharma, C.Straub, and L.Zawel (2006).
Development of Peptidomimetics Targeting IAPs.
  Int J Pept Res Ther, 12, 21-32.  
16282325 T.Samuel, K.Welsh, T.Lober, S.H.Togo, J.M.Zapata, and J.C.Reed (2006).
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
  J Biol Chem, 281, 1080-1090.  
17207090 X.Y.Hu, Y.M.Xu, X.C.Chen, H.Ping, Z.H.Chen, and F.Q.Zeng (2006).
Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
  APMIS, 114, 893-898.  
15880642 A.Loregian, and G.Palù (2005).
Disruption of protein-protein interactions: towards new targets for chemotherapy.
  J Cell Physiol, 204, 750-762.  
15610977 A.Wenzel, C.Grimm, M.Samardzija, and C.E.Remé (2005).
Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration.
  Prog Retin Eye Res, 24, 275-306.  
16184770 B.Jiang, W.Xiao, Y.Shi, M.Liu, and X.Xiao (2005).
Heat shock pretreatment inhibited the release of Smac/DIABLO from mitochondria and apoptosis induced by hydrogen peroxide in cardiomyocytes and C2C12 myogenic cells.
  Cell Stress Chaperones, 10, 252-262.  
15687241 B.Z.Carter, M.Gronda, Z.Wang, K.Welsh, C.Pinilla, M.Andreeff, W.D.Schober, A.Nefzi, G.R.Pond, I.A.Mawji, R.A.Houghten, J.Ostresh, J.Brandwein, M.D.Minden, A.C.Schuh, R.A.Wells, H.Messner, K.Chun, J.C.Reed, and A.D.Schimmer (2005).
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.
  Blood, 105, 4043-4050.  
16200201 C.W.Wright, and C.S.Duckett (2005).
Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.
  J Clin Invest, 115, 2673-2678.  
16283145 D.C.Fry, and L.T.Vassilev (2005).
Targeting protein-protein interactions for cancer therapy.
  J Mol Med, 83, 955-963.  
15650747 F.L.Scott, J.B.Denault, S.J.Riedl, H.Shin, M.Renatus, and G.S.Salvesen (2005).
XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.
  EMBO J, 24, 645-655.  
15814844 L.Burri, Y.Strahm, C.J.Hawkins, I.E.Gentle, M.A.Puryer, A.Verhagen, B.Callus, D.Vaux, and T.Lithgow (2005).
Mature DIABLO/Smac is produced by the IMP protease complex on the mitochondrial inner membrane.
  Mol Biol Cell, 16, 2926-2933.  
15939335 M.Arkin (2005).
Protein-protein interactions and cancer: small molecules going in for the kill.
  Curr Opin Chem Biol, 9, 317-324.  
16212486 N.Yan, and Y.Shi (2005).
Mechanisms of apoptosis through structural biology.
  Annu Rev Cell Dev Biol, 21, 35-56.  
16246265 N.Zhang, H.Hartig, I.Dzhagalov, D.Draper, and Y.W.He (2005).
The role of apoptosis in the development and function of T lymphocytes.
  Cell Res, 15, 749-769.  
16219456 P.G.Ekert, and D.L.Vaux (2005).
The mitochondrial death squad: hardened killers or innocent bystanders?
  Curr Opin Cell Biol, 17, 626-630.  
15764604 Q.Xie, T.Lin, Y.Zhang, J.Zheng, and J.A.Bonanno (2005).
Molecular cloning and characterization of a human AIF-like gene with ability to induce apoptosis.
  J Biol Chem, 280, 19673-19681.  
16239906 S.W.Fesik (2005).
Promoting apoptosis as a strategy for cancer drug discovery.
  Nat Rev Cancer, 5, 876-885.  
14749124 A.D.Schimmer, K.Welsh, C.Pinilla, Z.Wang, M.Krajewska, M.J.Bonneau, I.M.Pedersen, S.Kitada, F.L.Scott, B.Bailly-Maitre, G.Glinsky, D.Scudiero, E.Sausville, G.Salvesen, A.Nefzi, J.M.Ostresh, R.A.Houghten, and J.C.Reed (2004).
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.
  Cancer Cell, 5, 25-35.  
15328349 A.Trencia, F.Fiory, M.A.Maitan, P.Vito, A.P.Barbagallo, A.Perfetti, C.Miele, P.Ungaro, F.Oriente, L.Cilenti, A.S.Zervos, P.Formisano, and F.Beguinot (2004).
Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.
  J Biol Chem, 279, 46566-46572.  
14685266 E.Burstein, L.Ganesh, R.D.Dick, B.van De Sluis, J.C.Wilkinson, L.W.Klomp, C.Wijmenga, G.J.Brewer, G.J.Nabel, and C.S.Duckett (2004).
A novel role for XIAP in copper homeostasis through regulation of MURR1.
  EMBO J, 23, 244-254.  
15371416 J.C.Wilkinson, A.S.Wilkinson, F.L.Scott, R.A.Csomos, G.S.Salvesen, and C.S.Duckett (2004).
Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
  J Biol Chem, 279, 51082-51090.  
15371430 J.C.Wilkinson, B.W.Richter, A.S.Wilkinson, E.Burstein, J.M.Rumble, B.Balliu, and C.S.Duckett (2004).
VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation.
  J Biol Chem, 279, 51091-51099.  
15282301 J.C.Wilkinson, E.Cepero, L.H.Boise, and C.S.Duckett (2004).
Upstream regulatory role for XIAP in receptor-mediated apoptosis.
  Mol Cell Biol, 24, 7003-7014.  
15280366 J.Davoodi, L.Lin, J.Kelly, P.Liston, and A.E.MacKenzie (2004).
Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9.
  J Biol Chem, 279, 40622-40628.  
14701799 J.Lewis, E.Burstein, S.B.Reffey, S.B.Bratton, A.B.Roberts, and C.S.Duckett (2004).
Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis.
  J Biol Chem, 279, 9023-9029.  
15353805 L.Li, R.M.Thomas, H.Suzuki, J.K.De Brabander, X.Wang, and P.G.Harran (2004).
A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
  Science, 305, 1471-1474.  
15560849 M.Espinosa, D.Cantu, C.M.Lopez, J.G.De la Garza, V.A.Maldonado, and J.Melendez-Zajgla (2004).
SMAC is expressed de novo in a subset of cervical cancer tumors.
  BMC Cancer, 4, 84.  
15161430 M.Holcík (2004).
Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.
  Expert Opin Ther Targets, 8, 241-253.  
14689583 N.V.Guseva, A.F.Taghiyev, O.W.Rokhlin, and M.B.Cohen (2004).
Death receptor-induced cell death in prostate cancer.
  J Cell Biochem, 91, 70-99.  
15107838 N.Yan, J.W.Wu, J.Chai, W.Li, and Y.Shi (2004).
Molecular mechanisms of DrICE inhibition by DIAP1 and removal of inhibition by Reaper, Hid and Grim.
  Nat Struct Mol Biol, 11, 420-428.
PDB codes: 1sdz 1se0
15322527 S.C.Benn, and C.J.Woolf (2004).
Adult neuron survival strategies--slamming on the brakes.
  Nat Rev Neurosci, 5, 686-700.  
15292176 S.J.Gardai, B.B.Whitlock, Y.Q.Xiao, D.B.Bratton, and P.M.Henson (2004).
Oxidants inhibit ERK/MAPK and prevent its ability to delay neutrophil apoptosis downstream of mitochondrial changes and at the level of XIAP.
  J Biol Chem, 279, 44695-44703.  
15520809 S.J.Riedl, and Y.Shi (2004).
Molecular mechanisms of caspase regulation during apoptosis.
  Nat Rev Mol Cell Biol, 5, 897-907.  
15133027 S.Vyas, P.Juin, D.Hancock, Y.Suzuki, R.Takahashi, A.Triller, and G.Evan (2004).
Differentiation-dependent sensitivity to apoptogenic factors in PC12 cells.
  J Biol Chem, 279, 30983-30993.  
15371434 T.Yokokura, D.Dresnek, N.Huseinovic, S.Lisi, E.Abdelwahid, P.Bangs, and K.White (2004).
Dissection of DIAP1 functional domains via a mutant replacement strategy.
  J Biol Chem, 279, 52603-52612.  
15150408 V.P.Yin, and C.S.Thummel (2004).
A balance between the diap1 death inhibitor and reaper and hid death inducers controls steroid-triggered cell death in Drosophila.
  Proc Natl Acad Sci U S A, 101, 8022-8027.  
15189137 X.Jiang, and X.Wang (2004).
Cytochrome C-mediated apoptosis.
  Annu Rev Biochem, 73, 87.  
15201285 Y.M.Seong, J.Y.Choi, H.J.Park, K.J.Kim, S.G.Ahn, G.H.Seong, I.K.Kim, S.Kang, and H.Rhim (2004).
Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP.
  J Biol Chem, 279, 37588-37596.  
15273300 Y.Shi (2004).
Caspase activation, inhibition, and reactivation: a mechanistic view.
  Protein Sci, 13, 1979-1987.  
15337764 Z.Wang, M.Cuddy, T.Samuel, K.Welsh, A.Schimmer, F.Hanaii, R.Houghten, C.Pinilla, and J.C.Reed (2004).
Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors.
  J Biol Chem, 279, 48168-48176.  
14644196 A.Bergmann, A.Y.Yang, and M.Srivastava (2003).
Regulators of IAP function: coming to grips with the grim reaper.
  Curr Opin Cell Biol, 15, 717-724.  
12576135 A.Clerk, S.M.Cole, T.E.Cullingford, J.G.Harrison, M.Jormakka, and D.M.Valks (2003).
Regulation of cardiac myocyte cell death.
  Pharmacol Ther, 97, 223-261.  
12511567 A.M.Hunter, D.Kottachchi, J.Lewis, C.S.Duckett, R.G.Korneluk, and P.Liston (2003).
A novel ubiquitin fusion system bypasses the mitochondria and generates biologically active Smac/DIABLO.
  J Biol Chem, 278, 7494-7499.  
12973017 A.Saito, T.Hayashi, S.Okuno, M.Ferrand-Drake, and P.H.Chan (2003).
Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia.
  J Cereb Blood Flow Metab, 23, 1010-1019.  
12627942 D.Araç, T.Murphy, and J.Rizo (2003).
Facile detection of protein-protein interactions by one-dimensional NMR spectroscopy.
  Biochemistry, 42, 2774-2780.  
12620238 E.N.Shiozaki, J.Chai, D.J.Rigotti, S.J.Riedl, P.Li, S.M.Srinivasula, E.S.Alnemri, R.Fairman, and Y.Shi (2003).
Mechanism of XIAP-mediated inhibition of caspase-9.
  Mol Cell, 11, 519-527.
PDB code: 1nw9
12913864 G.H.Dihazi, and A.Sinz (2003).
Mapping low-resolution three-dimensional protein structures using chemical cross-linking and Fourier transform ion-cyclotron resonance mass spectrometry.
  Rapid Commun Mass Spectrom, 17, 2005-2014.  
12648453 I.S.Goping, M.Barry, P.Liston, T.Sawchuk, G.Constantinescu, K.M.Michalak, I.Shostak, D.L.Roberts, A.M.Hunter, R.Korneluk, and R.C.Bleackley (2003).
Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition.
  Immunity, 18, 355-365.  
14517550 J.Chai, N.Yan, J.R.Huh, J.W.Wu, W.Li, B.A.Hay, and Y.Shi (2003).
Molecular mechanism of Reaper-Grim-Hid-mediated suppression of DIAP1-dependent Dronc ubiquitination.
  Nat Struct Biol, 10, 892-898.
PDB code: 1q4q
12571250 J.Kuai, E.Nickbarg, J.Wooters, Y.Qiu, J.Wang, and L.L.Lin (2003).
Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis.
  J Biol Chem, 278, 14363-14369.  
12851935 M.Leone, R.A.Rodriguez-Mias, and M.Pellecchia (2003).
Selective incorporation of 19F-labeled Trp side chains for NMR-spectroscopy-based ligand-protein interaction studies.
  Chembiochem, 4, 649-650.  
12529384 M.Leverkus, M.R.Sprick, T.Wachter, T.Mengling, B.Baumann, E.Serfling, E.B.Bröcker, M.Goebeler, M.Neumann, and H.Walczak (2003).
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
  Mol Cell Biol, 23, 777-790.  
12565009 M.Los, C.J.Burek, C.Stroh, K.Benedyk, H.Hug, and A.Mackiewicz (2003).
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
  Drug Discov Today, 8, 67-77.  
12766759 N.Inohara, and G.Nuñez (2003).
NODs: intracellular proteins involved in inflammation and apoptosis.
  Nat Rev Immunol, 3, 371-382.  
12815069 Q.H.Yang, R.Church-Hajduk, J.Ren, M.L.Newton, and C.Du (2003).
Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.
  Genes Dev, 17, 1487-1496.  
13680844 T.Cserháti, E.Forgács, Z.Deyl, I.Miksik, and A.Echardt (2003).
Binding of low molecular mass compounds to proteins studied by liquid chromatographic techniques.
  Biomed Chromatogr, 17, 353-360.  
12967350 V.Leblanc, M.C.Dery, C.Shooner, and E.Asselin (2003).
Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus.
  Reprod Biol Endocrinol, 1, 59.  
12648450 V.R.Sutton, M.E.Wowk, M.Cancilla, and J.A.Trapani (2003).
Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors.
  Immunity, 18, 319-329.  
12660240 Z.Song, X.Yao, and M.Wu (2003).
Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
  J Biol Chem, 278, 23130-23140.  
12223312 A.Storey (2002).
Papillomaviruses: death-defying acts in skin cancer.
  Trends Mol Med, 8, 417-421.  
12218061 C.R.Arnt, M.V.Chiorean, M.P.Heldebrant, G.J.Gores, and S.H.Kaufmann (2002).
Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ.
  J Biol Chem, 277, 44236-44243.  
11801603 D.Vucic, K.Deshayes, H.Ackerly, M.T.Pisabarro, S.Kadkhodayan, W.J.Fairbrother, and V.M.Dixit (2002).
SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).
  J Biol Chem, 277, 12275-12279.  
12042762 G.S.Salvesen, and C.S.Duckett (2002).
IAP proteins: blocking the road to death's door.
  Nat Rev Mol Cell Biol, 3, 401-410.  
11818064 J.P.Wing, J.S.Karres, J.L.Ogdahl, L.Zhou, L.M.Schwartz, and J.R.Nambu (2002).
Drosophila sickle is a novel grim-reaper cell death activator.
  Curr Biol, 12, 131-135.  
12450324 J.Salgado, A.J.García-Sáez, G.Malet, I.Mingarro, and E.Pérez-Payá (2002).
Peptides in apoptosis research.
  J Pept Sci, 8, 543-560.  
11927604 J.Silke, C.J.Hawkins, P.G.Ekert, J.Chew, C.L.Day, M.Pakusch, A.M.Verhagen, and D.L.Vaux (2002).
The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites.
  J Cell Biol, 157, 115-124.  
12427028 L.E.Luque, K.P.Grape, and M.Junker (2002).
A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains.
  Biochemistry, 41, 13663-13671.  
12121969 M.MacFarlane, W.Merrison, S.B.Bratton, and G.M.Cohen (2002).
Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro.
  J Biol Chem, 277, 36611-36616.  
11964393 M.Rehm, H.Dussmann, R.U.Janicke, J.M.Tavare, D.Kogel, and J.H.Prehn (2002).
Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3.
  J Biol Chem, 277, 24506-24514.  
12042835 O.Gozani, M.Boyce, L.Yoo, P.Karuman, and J.Yuan (2002).
Life and death in paradise.
  Nat Cell Biol, 4, E159-E162.  
12011074 S.Li, Y.Zhao, X.He, T.H.Kim, D.K.Kuharsky, H.Rabinowich, J.Chen, C.Du, and X.M.Yin (2002).
Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis.
  J Biol Chem, 277, 26912-26920.  
12235153 T.Taverner, N.E.Hall, R.A.O'Hair, and R.J.Simpson (2002).
Characterization of an antagonist interleukin-6 dimer by stable isotope labeling, cross-linking, and mass spectrometry.
  J Biol Chem, 277, 46487-46492.  
11967569 W.Li, S.M.Srinivasula, J.Chai, P.Li, J.W.Wu, Z.Zhang, E.S.Alnemri, and Y.Shi (2002).
Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
  Nat Struct Biol, 9, 436-441.
PDB code: 1lcy
11801595 X.M.Sun, S.B.Bratton, M.Butterworth, M.MacFarlane, and G.M.Cohen (2002).
Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein.
  J Biol Chem, 277, 11345-11351.  
11931755 Y.Shi (2002).
Mechanisms of caspase activation and inhibition during apoptosis.
  Mol Cell, 9, 459-470.  
12401491 Z.Huang (2002).
The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules.
  Chem Biol, 9, 1059-1072.  
11738175 A.G.Cochran (2001).
Protein-protein interfaces: mimics and inhibitors.
  Curr Opin Chem Biol, 5, 654-659.  
  11516343 A.M.Verhagen, E.J.Coulson, and D.L.Vaux (2001).
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.
  Genome Biol, 2, REVIEWS3009.  
11406413 C.Adrain, and S.J.Martin (2001).
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas.
  Trends Biochem Sci, 26, 390-397.  
11257230 J.Chai, E.Shiozaki, S.M.Srinivasula, Q.Wu, P.Datta, E.S.Alnemri, Y.Shi, and P.Dataa (2001).
Structural basis of caspase-7 inhibition by XIAP.
  Cell, 104, 769-780.
PDB code: 1i51
11511363 J.W.Wu, A.E.Cocina, J.Chai, B.A.Hay, and Y.Shi (2001).
Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides.
  Mol Cell, 8, 95.
PDB codes: 1jd4 1jd5 1jd6
11290317 L.Goyal (2001).
Cell death inhibition: keeping caspases in check.
  Cell, 104, 805-808.  
11489640 P.Huang, and A.Oliff (2001).
Signaling pathways in apoptosis as potential targets for cancer therapy.
  Trends Cell Biol, 11, 343-348.  
11257232 S.J.Riedl, M.Renatus, R.Schwarzenbacher, Q.Zhou, C.Sun, S.W.Fesik, R.C.Liddington, and G.S.Salvesen (2001).
Structural basis for the inhibition of caspase-3 by XIAP.
  Cell, 104, 791-800.
PDB code: 1i3o
11711663 S.W.Fesik, and Y.Shi (2001).
Structural biology. Controlling the caspases.
  Science, 294, 1477-1478.  
  11257231 Y.Huang, Y.C.Park, R.L.Rich, D.Segal, D.G.Myszka, and H.Wu (2001).
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
  Cell, 104, 781-790.
PDB code: 1i4o
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer